What is MeiraGTx Holdings plc's R&D?

MeiraGTx Holdings plc (MGTX) reported R&D of $31.98M in Q1 2026.

How has MeiraGTx Holdings plc's R&D changed year-over-year?

MeiraGTx Holdings plc's R&D decreased by 2.4% year-over-year, from $32.78M to $31.98M.

What is the long-term trend for MeiraGTx Holdings plc's R&D?

Over 4 years (2021 to 2025), MeiraGTx Holdings plc's R&D has grown at a 18.1% compound annual growth rate (CAGR), from $66.69M to $129.62M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

MeiraGTx Holdings plc MGTX R&D

R&D at other companies

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

Opko HealthOPK

$29.2M-5.3%

Relay Therapeutics, Inc.RLAY

$70.56M-4.4%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

ALN

Alnylam PharmaceuticalsALNY

$364.87M+37.6%

Intellia TherapeuticsNTLA

$80.74M-25.5%

Other financials

Income statement

See full

Revenue$293.0K-84.8%

Operating income-$40.8M+1.9%

Net income-$46.3M-15.8%

EPS (diluted)-$0.57-11.8%

Balance sheet

See full

Cash & equivalents$71.5M+7.5%

Total debt$62.7M-22.5%

Total equity-$58.1M-276%

Total assets$244.7M+9.2%

Cash flow

See full

Operating cash flow$17.8M+148%

CapEx$2.0M+17.4%

Free cash flow$15.8M+141%

Valuation

See full

Market cap$1.07B+111%

Enterprise value$1.07B+103%

P/S13.5×-1.3×

Profitability

See full

Operating margin-597.9%-207pp

Net margin-615.3%—

FCF margin-441.5%-126pp

Returns & leverage

See full

Return on equity-379.5%—

Debt / equity27.2×+26.1×

Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MeiraGTx Holdings plc's R&D?: MeiraGTx Holdings plc (MGTX) reported R&D of $31.98M in Q1 2026.
How has MeiraGTx Holdings plc's R&D changed year-over-year?: MeiraGTx Holdings plc's R&D decreased by 2.4% year-over-year, from $32.78M to $31.98M.
What is the long-term trend for MeiraGTx Holdings plc's R&D?: Over 4 years (2021 to 2025), MeiraGTx Holdings plc's R&D has grown at a 18.1% compound annual growth rate (CAGR), from $66.69M to $129.62M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.